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Abstract
Background: Malaria in pregnancy is associated with maternal and foetal morbidity and mortality in endemic
areas, but information on imported cases to non-endemic areas is scarce.
The aim of this study was to describe the clinical and epidemiological characteristics of malaria in pregnancy in
two general hospitals in Madrid, Spain.
Methods: Retrospective descriptive study of laboratory-confirmed malaria in pregnant women at the Fuenlabrada
University Hospital and the Príncipe de Asturias University Hospital, in Madrid, over a six- and 11-year period,
respectively. Relevant epidemiological, clinical and laboratory data was obtained from medical records.
Results: There were 19 pregnant women among 346 malaria cases (5.4%). The average age was 27 years. The
gestational age (trimester) was: 53% 3
rd, 31% 1st, 16% 2
nd. All but one were multigravidae. Three were HIV positive.
All were sub-Saharan immigrants: two were recently arrived immigrants and seventeen (89%) had visited friends
and relatives. None had taken prophylaxis nor seeked pre-travel advice. Presentation: 16 symptomatic patients
(fever in fourteen, asthenia in two), three asymptomatic. Median delay in diagnosis: 7.5 days. Laboratory tests:
anaemia (cut off Hb level 11 g/dl) 78.9% (mild 31.6%, moderate 31.6%, severe 15.8%) thrombocytopaenia 73.7%,
hypoglycaemia 10.5%. All cases were due to Plasmodium falciparum, one case of hyperparasitaemia. Quinine +
clindamycin prescribed in 84%. Outcomes: no severe maternal complications or deaths, two abortions, fifteen term
pregnancies, no low-birth-weight newborns, two patients were lost to follow-up.
Conclusions: Though cases of malaria in pregnancy are uncommon, a most at risk group is clearly defined: young
sub-Saharan mothers visiting friends and relatives without pre-travel counselling and recently-arrived immigrants.
The most common adverse maternal and foetal effects were anaemia and stillbirth. Given that presentation can be
asymptomatic, malaria should always be considered in patients with unexplained anaemia arriving from endemic
areas. These findings could help Maternal Health programme planners and implementers to target preventive
interventions in the immigrant population and should create awareness among clinicians.
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Background
Malaria in pregnancy is known to be a primary cause of
morbidity and mortality in both mother and foetus in
endemic areas. It is in this setting that this form of
malaria is being extensively studied and where current
knowledge derives from. Information on the incidence
and relevance of this particular type of malaria in non-
endemic, industrialized areas is scarce [1-3]. Though
malaria vanquished from Spain in 1964, arrival of
migrants from endemic areas and increased interna-
tional tourism during the past 2 decades has led to a
reemergence of this parasitic disease as an imported
infection. In fact, falciparum malaria is one of the most
common potentially fatal tropical diseases that can be
imported to Spain.
In Spain, around 350-400 cases of malaria/year have
been reported in the past five years to the national com-
municable diseases database, though it is estimated that
the total number of imported cases is over 400, because
of under-reporting. The majority are due to Plasmodium
falciparum. The region of Madrid registers a propor-
tionally large number of cases: 21-37% of all malaria
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were reported from Madrid. In 2009, the incidence rate
(IR) was 2,0/100,000, three-times higher than the
national IR [4].
Within the region of Madrid, a high proportion of
cases are reported from the southern and eastern areas
where a large number of migrants originally from ende-
mic areas have settled. The Fuenlabrada University Hos-
pital (FUH) and the Príncipe de Asturias University
Hospital (PAUH) are both located in these two particu-
larly migrant populated areas. Nonetheless, as reported
by the regional surveillance network, these hospitals
diagnosed 53% of malaria cases in Madrid in both 2008
and 2009, despite only 10% of total regional population
living in these areas [4].
Although imported malaria to Spain has already been
described in several reports from different regions and
health care settings and guidelines highlighting the risk
and prevention strategies during pregnancy have been
published, little is known about the relevance and char-
acteristics of imported malaria during pregnancy [5,6].
The aim of this study was to describe the clinical and
epidemiological characteristics and outcomes of malaria
in pregnancy in these two general hospitals in a non-
endemic country.
Methods
A retrospective descriptive review was conducted on all
pregnant women with laboratory confirmed malaria
diagnosed in the PAUH and the FUH, during the period
January 1
st 2000 to June 1
st 2011 and January 1
st 2005
to June 1
st 2011, respectively. Laboratory criteria used
for confirmation of diagnosis was the demonstration of
asexual forms of malaria parasites in a thick and/or thin
blood film. Positive antigen detection (second generation
test for rapid detection of P. falciparum antigen-
PfHRP2) and positive polymerase chain reaction test for
Plasmodium nucleic acid was considered additional sup-
port to diagnosis. Clinical, epidemiological and labora-
tory information was collected from medical records.
Demographic characteristics included age, country of
origin, time elapsed since arrival to Spain, reason for
travel to endemic area (migrant visiting friends and rela-
tives-VFR- or national traveller) and recently arrived
migrant status. Epidemiological data included: area
where malaria was acquired from (last endemic area vis-
ited), month, incubation period (number of days elapsed
between the last day in endemic area till symptom
onset), delay in diagnosis (days from symptom onset till
microbiological diagnosis) and written evidence of any
pre-travel advice.
Clinical data collected included previous medical his-
tory (co-morbid conditions), current presentation classi-
fied as fever, flu-like, gastrointestinal or respiratory
symptoms and other presentations, WHO criteria for
severe malaria (WHO, 2006), any remarkable clinical
sign observed at diagnosis and information on chemo-
prophylaxis (no/inadequately taken prophylaxis or ade-
quate prophylaxis).
Laboratory data included anaemia assessment accord-
ing to WHO standards (anaemia was considered present
when haemoglobin (Hb) < 11 g/dl; cut off levels for
mild, moderate and severe anaemia were Hb 9-10.9 g/dl,
Hb7.1-8.9 g/dl and Hb < 7 g/dl, respectively), platelet
count and classification as mild (100,000-150,000/mm
3),
moderate (80,000-100,000/mm
3) and severe (< 80,000/
mm
3) thrombocytopenia and any other remarkable
laboratory finding at diagnosis. Microbiological data
included Plasmodium species, parasitaemia at diagnosis,
and results of rapid diagnostic tests and PCR if they had
been carried out. Information on the treatment pre-
scribed and clinical and parasitological follow-up at days
3, 7 and 30 after treatment onset was also collected.
Obstetrical data collected included parity, gestational
age at diagnosis, prior obstetrical classification as high-
risk pregnancy and reason for the patient being classi-
fied as such, timing of delivery, pregnancy outcomes
and newborn birth weight (low birth weight-LBW-
defined as < 2500 g). Continuous variables are reported
as mean +/- standard deviation (SD) or median and
interquartile range (IR). Categorical variables are
reported as frequencies and percentage of each category.
Results
There were 19 malaria cases in pregnant women among
346 malaria cases diagnosed in both institutions during
the study period (5.4%). Demographical, epidemiological,
clinical, microbiological and laboratory characteristics
are summarized in Table 1.
All but one were multigravidae. All patients were
young sub-Saharan African women, mainly from Equa-
torial Guinea (58%). There were no national travellers.
All but two (89%) were VFR. Median time living in
Spain of the 15 VFR for whom this information was
available was 6 years (IR 10 months-10 years). The two
non-VFR patients were recently arrived immigrants to
Spain, one month and six months before clinical presen-
tation, respectively.
Malaria was acquired in their countries of origin in all
cases except for one patient who had visited relatives in
another endemic country. There was no written evi-
dence of any pre-travel advice in any case and none had
correctly taken chemoprophylaxis. Sixteen patients
(83.5%) had acquired malaria travelling during either
summer or Christmas holiday periods. No information
was available on intermittent preventive treatment.
The majority of patients (58%) did not have any other
medical condition prior to malaria. There were three
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Page 2 of 8Table 1 Clinical and epidemiological characteristics and outcomes of 19 cases of imported malaria in pregnancy
Variables Frequency (%)
Country of Origin
Equatorial Guinea 11 (57.9)
Nigeria 6 (31.6)
Congo 1 (5.3)
Ghana 1 (5.3)
Mean Age Years (+/- SD) 27 (+/-5.3)
Reason for Travel
VFR 17 (89.5)
National Traveller 0
Recent Immigration Yes 2 (10.5)
Chemoprophylaxis
None/Incorrect/Incomplete 19 (100)
Co-morbidities
None 11 (57.9)
HIV 3 (15.8)
Hypertension 1 (5.3)
Smoker 1 (5.3)
Other 3 (15.8)
Gestational Age
Third Trimester 10 (52.6)
Second Trimester 3 (15.8)
First Trimester 6 (31.6)
Parity
Multigravidae 18 (94.7)
Primigravidae 1 (5.3)
Classification As High Risk Pregnancy Yes 6 (31.6)
Clinical Presentation
-Asymptomatic 3 (15.8)
-Symptomatic 16 (84.2)
Fever 14 (73.6)
Fever Alone 7 (36.8)
Fever + Gastrointestinal 4 (21.1)
Fever + Flu-Like Symptoms 3 (15.8)
Other 2 (10.5)
- Signs
None 17 (89.5)
Splenomegaly (At examination and/or ultrasound) 1 (5.3)
Hepatosplenomegaly (At examination and/or ultrasound) 1 (5.3)
Laboratory Findings
-Anaemia (Hb < 11 g/Dl) 15 (78.9)
Mild (9-10.9 g/Dl) 6 (31.6)
Moderate (7-8.9 G/Dl) 6 (31.6)
Severe (Hb < 7 g/Dl) 3 (15.8)
-Thrombocytopaenia (< 150,000/Mm
3) 14 (73.7)
Mild (100,000-150,000/Mm
3) 8 (42.1)
Moderate (80,000-10,000/Mm
3) 2 (10.5)
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Page 3 of 8HIV positive women: two CDC stage A2 and one A1.
Six pregnancies (32%) had previously been classified as
high risk. The reasons for this classification were: HIV
positivity in three cases, hypertension in one case, gesta-
tional diabetes in another case and, finally, one patient
was undergoing close follow-up because of a history of
fever during her stay in Africa.
There were three asymptomatic cases. The predomi-
nant clinical syndrome among the symptomatic women
was fever (14 patients) with or without associated symp-
toms. The 2 symptomatic non-febrile women referred
asthenia as major complaint. Malaria parasites were
detected in the three asymptomatic cases because of dif-
ferent diagnostic work-ups: in one case, the patient was
being studied for unexplained 3
rd trimester severe anae-
mia, in one of the HIV positive patients both malaria
and microfilariae were observed in the course of a
routine 3
rd trimester blood test, the other HIV positive
patient was found to have malaria after the finding of an
unexplained hepatosplenomegaly during a routine obste-
tric ultrasound. Other than this patient and another
patient with splenomegaly, clinical examination was
unremarkable in all cases.
Date of symptom onset was recorded in 15 of the
symptomatic cases. Symptom onset occurred while still
in an endemic area in five cases (17 days to 1 day before
returning to Spain). Nine patients started referring
symptoms once in Spain, ranging from seven to 69 days
after the last day in the endemic area (median 11 days;
IR 3.5-36 days). Median delay in diagnosis was 7.5 days
(IR 2.7-21.7 days). In 7 cases, diagnosis was made more
than one week after symptom onset.
None of the patients presented clinical features for
severe malaria and only in one case was a laboratory
Table 1 Clinical and epidemiological characteristics and outcomes of 19 cases of imported malaria in pregnancy
(Continued)
Severe (< 80,000/Mm
3) 4 (21.1)
-Hypoglycaemia (Serum Glucose < 60 Mg/Dl, With Or Without Symptoms) 2 (10.5)
Microbiology
- P. falciparum (One Mixed Infection) 19 (100)
Parasitaemia > 4% 1 (5.3)
Parasitaemia 1-4% 5 (26.3)
Parasitaemia < 1% 11 (57.9)
No data 2 (26.3)
Diagnostic delay days Median (IR) 7.5 (2.7-21.7)
Treatment
Quinine + Clindamycin 16 (84.2)
Mefloquine 1 (5.3)
Atovaquone + Proguanil* 2 (10.5)
Maternal outcome
- Death 0 (0)
-Clinical complications 0 (0)
-Anaemia improvement (N = 15) Yes 9 (60)
No data 6 (40)
Foetal outcome
-Abortion 2 (10.5)
-Delivery Term 15 (78.9)
No data (Lost to follow-up) 2 (10.5)
-Birth weight N = 15 > 2,500 g 15 (100)
< 2,500 g 0 (0)
Parasitological follow-up
Undetectable parasitaemia 12 (63.2)
No data 7 (38.9)
VFR: visiting friends and relatives
SD: standard deviation
IR: interquartile range (25
th-75
th percentile)
* Two patients received atovaquone-proguanil: one after premature abortion and another after term delivery
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frequent laboratory finding was anaemia, (79%), followed
by thrombocytopaenia (74%) and hypoglycaemia (two
cases, both asymptomatic and over 40 mg/dl, cut off
level for severe malaria).
All cases were P. falciparum malaria, with one mixed
infection. A rapid diagnostic test was used as comple-
mentary diagnostic support in 12 cases, and PCR testing
was carried out in eight cases, yielding positive results for
P. falciparum in all cases. Data on parasitological follow-
up was incomplete. Twelve patients had confirmed nega-
tive parasitaemia at any time during follow-up.
The majority of cases (84%) were treated with quinine
plus clindamycin. Patients with severe anaemia received
blood transfusions. There were no maternal complica-
tions or deaths. Pregnancy outcomes were favourable in
15 cases: all term pregnancies, no low birth weight new-
borns. There were two premature abortions. Anaemia
was reassessed in 10 patients; in all but one there was
an increase in Hb levels after treatment.
Discussion
This study describes the characteristics of 19 P. falci-
parum malaria cases among pregnant women attending
the two suburban general hospitals where a large pro-
portion of malaria cases are reported from in the region
of Madrid. Results show that, though this presentation
is uncommon, a most at risk group is clearly defined:
young sub-Saharan mothers visiting friends and relatives
without pre-travel counselling and recently arrived
immigrants.
Pregnant women are at increased risk for malaria
infection. Increased susceptibility has long been recog-
nized and multiple factors have been identified, yet,
there are still many gaps in knowledge that need to be
addressed. Placental infected erythrocytes differ from
those found in peripheral blood because they present
surface antigens that act as ligands permitting adhesion
to chondroitin-sulphate A receptors in the intervillous
space. IgG antibodies against pregnancy specific para-
sites are gradually developed resulting in a unique form
of immunity: parity-specific immunity.
Thus, in endemic areas, the clinical impact varies
depending on transmission. In highly endemic areas
with stable transmission, the frequency and severity of
the infection is higher in primigravidae than multigravi-
dae, while, in hypoendemic areas with unstable trans-
mission, women have less opportunity to develop parity-
specific immunity and so are e q u a l l ys u s c e p t i b l ea c r o s s
the parity.
Malaria is associated with maternal and foetal morbid-
ity and mortality. Percentages of maternal deaths vary
depending on studies: up to 23% or up to 17% in hospi-
tal-based and community-based studies in Africa, respec-
tively [7]. The most deleterious effects are caused by
P. falciparum. In areas of high transmission, severe anae-
mia is common and is associated with morbidity and
mortality. Foetal disease presents as preterm delivery,
Table 2 Key clinical and epidemiological findings from three previous studies
Subramanian D [2] Westeyn JC [3] Botelho-Nevers E [1]
Year publication 1992 1995 2005
Institution, country General hospital, U.S.A Royal Tropical Institute, The Netherlands Two maternity wards, France
N° cases (period) 4 (8 months) 10 among 1444 imported malaria cases (9
years)
18 (5 years)
Epidemiological
data
3 VFR
1 recently arrived migrant
Average age 28
No data on
chemoprophylaxis
Not specified
2 adequate chemoprophylaxis
16 VFR
2 national travellers
Average age 27
15 no chemoprophylaxis, 3 incomplete
Obstetrical data 1 primigravidae
3 multigravidae
Not specified 4 primigravidae
14 multigravidae
Clinical data
Presentation Fever (4/4)
Diagnostic delay (2/4)
Not specified Fever at or 48 hours before presentation (18/18)
Complications Anaemia (4/4) Not specified (6/10) Anaemia (18/18)
Severe malaria: Hb < 5 g/dl (2/18) Hypoglycemia
(2/18)
Maternal
death
1/4 None None
Foetal
outcome
1 congenital malaria (P.
vivax)
Not specified 1 premature abortion
2 late abortions
1 premature delivery
1 low birth weight
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increased risk of death in infancy, whether or not mater-
nal symptoms are detected during pregnancy [8]. Unfor-
tunately, it is difficult to estimate the burden of disease in
non-endemic areas since epidemiological and clinical data
is scarce and based on isolated cases, small series or
cases within large series [1-3].
In the United States, basic epidemiological data is
available from the Centre for Disease Control surveil-
lance summaries. For instance, in 2005, a total of 21
cases of malaria were reported among pregnant women,
representing 4% of cases among women. Among these,
66% were U.S. civilians and only one third reported tak-
ing malaria chemoprophylaxis [9].
In Europe, international surveillance networks on
imported diseases do not specify the number of preg-
nant women within female malaria cases in the patient
characteristics topic [10]. In Spain, there is a lack of epi-
demiological and clinical data from pregnant women, as
this item is not always coded in the communicable dis-
eases’ sheet. This is the first description of imported
malaria in pregnancy to Spain and one of the few case
series in Europe [1,3].
Previous reports on imported malaria have already
described the high density of migrant population within
the catchment population of both hospitals and the high
proportion of immigrants not taking correct prophylaxis
[5]. Given that a large proportion of Spain’s malaria
cases are reported from Madrid, and particularly from
the south and eastern districts with annual incidence
rates around 7/100,000 population during the last dec-
ade, this case series could describe the actual picture of
imported malaria in pregnancy in Spain.
Table 2 summarizes the key epidemiological and clini-
cal characteristics from previous case descriptions. Inter-
estingly, though VFRs have been previously identified as
a major risk group for imported malaria to Europe, the
present and previous case series highlight the fact that,
still, VFRs remain a most at risk group during preg-
nancy and should be better targeted for preventive inter-
ventions [11].
There were neither national travellers nor patients
from other endemic areas such as Latin America or
Asia, though few malaria cases within this other groups
have been reported in both hospitals. The large propor-
tion of sub-Saharan immigrants compared to those of
different origin and the fact that tropical areas are an
uncommon travel destiny among the national low-mid-
dle income population attended at our institutions could
explain this finding. Less severe presentations due to P.
vivax in Latin American pregnant women could also
possibly be misdiagnosed. Globally, results from the
European Network on Tropical Diseases show that the
proportion of imported cases caused by P. falciparum in
VFR has increased in the last decade. Concomitantly,
patient characteristics are different in the other malaria
species, where European travellers make up the predo-
minant group. The present and previous studies are
consistent with the epidemiological trend in Europe and
lead to several questions [10].
First, from the patients’ side, are sociocultural and
demographic variables influencing on perceived sus-
ceptibility and severity of malaria in pregnancy and
recognition of malaria and anaemia during pregnancy?
Frequently, migrants travelling to their countries of ori-
gin mistakenly believe that they retain lifelong immunity
and do not seek advice prior to travel nor take appropri-
ate prophylaxis, as was observed in this and previous
studies. Also, illness recognition may be hindered and
women might confuse malaria symptoms with preg-
nancy-related symptoms. Socio-cultural aspects on the
specific topic of malaria in pregnancy have received little
attention in endemic areas [12]. Furthermore, health-
seeking behaviour, knowledge, attitudes and perceptions
towards pregnancy and pregnancy-related risks in the
field of malaria within the immigrant population are
under-researched in non-endemic countries. Health pro-
motion to this vulnerable group needs to be better
addressed.
From the health system’s side, is there availability and
accessibility of health advice in antenatal care clinics
and primary care regarding malaria? Health staff attend-
ing pregnant immigrant women is crucial in recognizing
the potential risk of travel and in considering malaria
when a diagnostic work-up is carried out. A large pro-
portion of immigrant patients seek care in general hos-
pitals, situated near their homes, where a tropical
diseases department is not always available. Pregnant
women are usually attended by obstetricians and general
practitioners, who might not be familiarized with this
type of malaria. In this study, pregnancies were classified
as high risk because of co-morbid conditions and not
because of malaria exposure risk. Only in one case
exposure was considered, and this was because the
patient had had fever during her stay. Awareness of this
issue should be raised among physicians, midwives and
health policy makers.
Regarding clinical presentation, in malaria, nature of
effects depends on the patient’s background premuni-
tion. In pregnancy, parity-specific immunity is crucial
a n dl i t t l ei sk n o w na b o u tl o s so ft h i ss p e c i f i ci m m u n i t y
years after leaving an endemic zone.
Among the sixteen symptomatic patients, symptoms
were non-specific with a predominance of fever and the
median diagnostic delay was 7 days. Previous series have
attributed delays to misdiagnoses with common illnesses
due to unfamiliarity with the disease [2]. The two symp-
tomatic though non-febrile patients referring asthenia
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and presented the longest delay in diagnosis. One was a
recently arrived immigrant and the other had been in
Spain for five years, suggesting the persistence of low
level immunity able to restrict parasitaemia. On the
other hand, an inappropriate health-seeking behaviour
due to unperceived pregnancy-related risk and the per-
ception of symptoms as “normal” pregnancy symptoms
might contribute to diagnostic delay.
Similarly, absence of symptoms in three patients might
have been due to some degree of pre-existing immunity
retained during pregnancy, though time living in Spain
ranged widely from four months to six years. Many
pregnant women living in high transmission areas are
known to remain asymptomatic. It is noteworthy that
two asymptomatic patients had anaemia, one of which
was severe. In fact, a study in Mozambique found no
evidence of association between signs and symptoms
suggestive of malaria and the presence of microscopi-
cally detected peripheral malaria, but anaemia was the
only sign associated with sub-microscopic parasitaemia
detected exclusively by PCR, suggesting that low density
asymptomatic infections may increase the risk of anae-
mia [13].
Anaemia (WHO definition: haemoglobin ≤ 11 g/dl) is
one of the world’s leading causes of disability, affecting
nearly half of all pregnant women in the world: 52% in
developing countries, 23% in the developed world [14].
A strong association between severe anaemia and mater-
nal mortality has been found and associated perinatal
outcomes have been documented [15]. Reduction of
anaemia is thus a key component of safe motherhood.
One of the most common causes of anaemia is
malaria. In the study on sub-microscopic P. falciparum
malaria in Mozambican pregnant women, risk of mater-
nal anaemia was higher in PCR positive women than in
PCR negative (OR 1.92 CI 1.09-3.36) [13]. WHO recom-
mends anti-malarial treatment in pregnant women with
severe anaemia living in areas where the risk of P. falci-
parum infections is high even in the absence of parasi-
taemia [16]. Anaemia was the most common maternal
consequence of malaria in the present and previous stu-
dies, even in otherwise asymptomatic patients. Three
patients presented severe anaemia requiring blood trans-
fusion in addition to anti-malarials. The incidence of
maternal anaemia is higher in first pregnancies in malar-
ious areas as a consequence of increased parasite preva-
lence and severity of infection. The only primigravid
patient came to hospital at the end of pregnancy and
referred no other symptoms apart from those attributed
to labour. But, contrarily, she had severe anaemia and it
was this finding that finally led to the diagnosis of
malaria. It is, therefore, important to identify anaemic
patients and to consider malaria as a possible underlying
cause in any pregnant woman with exposure history in
order to treat them adequately.
Other complications observed in the present and in
previous reports were hypoglycaemia and splenomegaly.
Similarly to the French series, there were no maternal
deaths nor other complications apart from those men-
tioned above, suggesting that probably, this mainly mul-
tigravidae group of women retained a certain level of
parity-specific immunity years after leaving endemic
areas. But adverse foetal outcomes in both series did
occur in the form of abortions and preterm delivery of a
LBW neonate. One fatal maternal case was described in
the U.S. report: this patient was primigravidae, diagnosis
was delayed and she progressed towards severe compli-
cations (hypoglycaemia and respiratory distress) [2].
Thus, globally, clinical suspicion in a non-endemic
area such as Spain may be challenging due to the unfa-
miliarity with the disease and with the link between
anaemia and malaria and the low specificity of clinical
complaints and signs. Prompt diagnosis and treatment
will depend on illness recognition and the women’s
health-seeking behaviour based on her perceived sus-
ceptibility to malaria.
During pregnancy, asymptomatic low parasite densi-
ties and parasites sequestered in the placenta are harm-
ful to the mother and foetus, and the sensitivity of
microsocopy might be insufficient in these cases. More-
over, parasitaemia can fluctuate and be kept under level
of detection by acquired immunity or self-medication,
particularly late in pregnancy, and recrudescences can
occur later than in non-pregnant patients [13]. This can
make diagnosis difficult to less experienced and trained
microscopists in non-endemic areas.
Patients received treatment following current guide-
lines and depending on availability of drugs. Following
treatment it is necessary to reliably confirm infection
and clearance of parasites. In this study, follow up of
nearly 40% of patients was not complete to guarantee
parasite clearance. But, assessment of the efficacy of
treatment is complicated. Except when the treatment
occurs near delivery, to know whether current regimens
a r ea b l et oc l e a rp l a c e n t a lp a r asites requires sensitive
diagnostic tools. PCR allows the identification of parasi-
taemia levels below the threshold of microscopy and can
be useful in predicting adverse outcomes in pregnancy
[17].
Acquired anti-malarial immunity depends not only on
the intensity of transmission and the number of pre-
vious pregnancies, but also on the presence of condi-
tions that decrease immunity such as HIV infection.
HIV infection restricts the development of parity-speci-
fic immunity, has an additive effect on LBW and anae-
mia and has been shown to cause more clinical malaria
and higher parasitaemia in perennial transmission areas,
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areas with seasonal transmission. Regarding the role of
placental malaria in HIV mother to child transmission
(MTCT), results are controversial. Both maternal HIV
RNA viral load and anaemia are independent risk fac-
tors for MTCT [18]. There were three patients with
HIV coinfection. Surprisingly, two of them presented no
symptoms but did have anaemia. All classified as CDC
category A, stages 1 and 2 which may have resulted in
an unremarkable clinical progress, without adverse foetal
outcomes. Other than the significant prevalence of coin-
fection in this series (15%), no other conclusions can be
drawn due to the small number of patients.
Conclusions
This is a small-sample size, retrospective, hospital-based
descriptive study with the limitations that pertain to the
nature of the study design. Nevertheless, these findings
highlight that falciparum malaria needs to be considered
as a differential diagnosis when dealing with pregnant
women who might have been exposed in endemic areas,
particularly sub-Saharan VFRs, even in the absence of
symptoms, and should be especially considered in
patients with unexplained anaemia.
Uptake of chemoprophylaxis is still low in immigrant
travellers. Hence, tailoring health messages to immigrant
groups is a priority and access to information on pre-
vention, chemoprophylaxis and health-seeking attitudes
should be made available to immigrants in general
hospitals.
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